Insider · CIK 0001166598
Raymond J. Lane
director
Files at HPE (Hewlett Packard Enterprise Co). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | HPE Hewlett Packard Enterprise Co | AGrant or award Common Stock | +509 | $63.89 | $33k | 990,793 | 10 d ago |
| Jul 15, 2026 | HPE Hewlett Packard Enterprise Co | AGrant or award Restricted Stock Unitsderivative | +26 | - | - | 8,776 | 10 d ago |
| May 2, 2025 | HPE Hewlett Packard Enterprise Co | AGrant or award Restricted Stock Unitsderivative | +14,235 | - | - | 14,235 | May 6, 2025 |
| Apr 2, 2025 | HPE Hewlett Packard Enterprise Co | MOption exercise Common Stock | +14,323 | $16.12 | $231k | 969,707 | Apr 4, 2025 |
| Apr 2, 2025 | HPE Hewlett Packard Enterprise Co | MOption exercise Restricted Stock Unitsderivative | -14,323 | - | - | 0 | Apr 4, 2025 |
| Apr 1, 2025 | HPE Hewlett Packard Enterprise Co | AGrant or award Common Stock | +1,838 | $15.64 | $29k | 955,384 | Apr 3, 2025 |
| Jan 16, 2025 | HPE Hewlett Packard Enterprise Co | AGrant or award Restricted Stock Unitsderivative | +78 | - | - | 14,323 | Apr 3, 2025 |
| Dec 15, 2024 | HPE Hewlett Packard Enterprise Co | AGrant or award Common Stock | +1,317 | $21.83 | $29k | 953,546 | Dec 17, 2024 |
| Oct 18, 2024 | HPE Hewlett Packard Enterprise Co | AGrant or award Restricted Stock Unitsderivative | +88 | - | - | 14,245 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.